VX-548 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Painful Lumbosacral Radiculopathy
Conditions
Painful Lumbosacral Radiculopathy
Trial Timeline
Dec 13, 2023 → Oct 16, 2024
NCT ID
NCT06176196About VX-548 + Placebo
VX-548 + Placebo is a phase 2 stage product being developed by Vertex Pharmaceuticals for Painful Lumbosacral Radiculopathy. The current trial status is completed. This product is registered under clinical trial identifier NCT06176196. Target conditions include Painful Lumbosacral Radiculopathy.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06176196 | Phase 2 | Completed |
Competing Products
20 competing products in Painful Lumbosacral Radiculopathy